Evidence map›Paper›PMID 33621475›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2021

Insulin-like growth factor 1 signaling in the placenta requires endothelial nitric oxide synthase to support trophoblast function and normal fetal growth.

Rebecca L Wilson, Weston Troja, Emily K Sumser, Alec Maupin, Kristin Lampe, Helen N Jones

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Inositol-Exchange Activity in Human Primordial Placenta.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rebecca L WilsonDepartment of Physiology and Functional Genomics, University of Florida, Gainesville, Florida.ORCID 0000-0002-3867-7784
Weston TrojaCenter for Fetal and Placental Research, Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio.
Emily K SumserCenter for Fetal and Placental Research, Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio.
Alec MaupinCenter for Fetal and Placental Research, Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio.
Kristin LampeCenter for Fetal and Placental Research, Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio.
Helen N JonesDepartment of Physiology and Functional Genomics, University of Florida, Gainesville, Florida.
Cincinnati Children's Hospital Medical Center · USUniversity of Florida · US

Funding

Placental-specific therapy for fetal growth restrictionR01HD090657 · NICHD · UNIVERSITY OF FLORIDA · PI HELEN N JONES · 2017 to 2026
$2.6M
HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD090657NICHD NIH HHS R01 HD090657
6 · The paper itself

Abstract

Currently, there is no effective treatment for placental dysfunction in utero. In a ligated mouse model of fetal growth restriction (FGR), nanoparticle-mediated human insulin-like 1 growth factor (

Indexed as

Genetic TherapyNeovascularization, PhysiologicADAM10 ProteinAmyloid Precursor Protein SecretasesAnimalsCell Line, TumorDisease Models, AnimalFemaleFetal DevelopmentFetal Growth RetardationFetusGene Transfer TechniquesHypoxia-Inducible Factor 1, alpha SubunitInsulin-Like Growth Factor IMaleMembrane ProteinsADAM10 ProteinADAM10 protein, humanAmyloid Precursor Protein SecretasesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIGF1 protein, humanInsulin-Like Growth Factor IMembrane ProteinsNitric Oxide Synthase Type IIINOS3 protein, humanNos3 protein, mouseendothelial nitric oxide synthasefetal growth restrictioninsulin-like growth factor 1nanoparticleplacenta

Identifiers

PMID33621475
PMCPMC8163607
OpenAlexW3132847445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.